Clinical Trial 6235

Conyers, GA 30094

Study Summary:

Individuals with colorectal cancer that has metastasized (spread) are invited to inquire about participation in a clinical research study. This study will evaluate an investigational fully human monoclonal antibody combined with chemotherapy to see if it will extend survival for a longer period of time, compared to the best available standard of care regimen. Monoclonal antibodies are substances produced in a laboratory that can locate and bind to cancer cells by recognizing specific substances on cancer cells. These antibodies are used to find and attack tumors. counter for myspace

Qualified Participants Must:

• Have unresectable (inoperable) colorectal cancer that has metastasized (spread)
• Be at least 18 years of age
• Not have received a prior treatment regimen for their advanced-stage colorectal cancer
• Meet other enrollment criteria

Qualified Participants May Receive:

Study-related medication and study-related procedures at no cost

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.